Primecap Management Co. CA Trims Holdings in 908 Devices Inc. (NASDAQ:MASS)

Primecap Management Co. CA lowered its position in shares of 908 Devices Inc. (NASDAQ:MASS) by 19.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 20,000 shares of the company’s stock after selling 4,830 shares during the period. Primecap Management Co. CA’s holdings in 908 Devices were worth $69,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of MASS. Vanguard Group Inc. lifted its stake in shares of 908 Devices by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 1,751,102 shares of the company’s stock valued at $13,221,000 after buying an additional 6,772 shares in the last quarter. AWM Investment Company Inc. raised its holdings in 908 Devices by 2.3% during the first quarter. AWM Investment Company Inc. now owns 668,526 shares of the company’s stock valued at $5,047,000 after acquiring an additional 15,058 shares during the period. Millennium Management LLC lifted its position in shares of 908 Devices by 35.5% in the second quarter. Millennium Management LLC now owns 618,310 shares of the company’s stock valued at $3,184,000 after acquiring an additional 161,922 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of 908 Devices by 88.3% in the second quarter. Dimensional Fund Advisors LP now owns 245,176 shares of the company’s stock worth $1,263,000 after acquiring an additional 114,987 shares during the period. Finally, Renaissance Technologies LLC grew its position in shares of 908 Devices by 79.4% during the second quarter. Renaissance Technologies LLC now owns 195,500 shares of the company’s stock worth $1,007,000 after purchasing an additional 86,500 shares in the last quarter. 88.06% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on MASS shares. Leerink Partnrs cut 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th. Stifel Nicolaus lowered their target price on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Finally, Leerink Partners reaffirmed a “market perform” rating and set a $4.00 target price (down from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th.

908 Devices Trading Down 6.6 %

Shares of 908 Devices stock opened at $2.56 on Friday. The firm has a market cap of $89.14 million, a PE ratio of -1.45 and a beta of 0.98. The stock has a 50 day moving average of $3.32 and a 200 day moving average of $4.55. 908 Devices Inc. has a 12 month low of $2.19 and a 12 month high of $12.51.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.